STOCK TITAN

Natera Announces Second Quarter 2021 Earnings Conference Call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

AUSTIN, Texas, July 29, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that it will release results for its second quarter ended June 30, 2021, after the market close on August 5, 2021. Natera will host a conference call and webcast at 1:30 p.m. PT (4:30 p.m. ET) to discuss its financial results, business activities, and financial outlook.

Earnings Conference Call Information:



Event:          

Natera's Second Quarter 2021 Financial Results Conference Call



Date:             

Thursday, August 5, 2021



Time:              

1:30 p.m. PT (4:30 p.m. ET)



Live Dial-In:     

(877) 823-0171, Domestic
(617) 500-6932, International



Password:        

4434144



Webcast:        

https://edge.media-server.com/mmc/p/oe2yd2em

A webcast replay will be available at investor.natera.com.

About Natera

Natera is a pioneer and global leader in cell-free DNA testing from a simple blood draw. The mission of the company is to change the management of disease worldwide with a focus on women's health, oncology, and organ health. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. It offers proprietary genetic testing services to inform obstetricians, transplant physicians, oncologists, and cancer researchers, including biopharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn.

Contacts
Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-826-2350
Media: Kate Stabrawa, Communications, Natera, Inc., pr@natera.com     

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/natera-announces-second-quarter-2021-earnings-conference-call-301343978.html

SOURCE Natera, Inc.

Natera, Inc.

NASDAQ:NTRA

NTRA Rankings

NTRA Latest News

NTRA Stock Data

13.18B
116.45M
4.1%
96.19%
5.17%
Medical Laboratories
Health Care and Social Assistance
Link
United States of America
AUSTIN

About NTRA

natera is a san carlos, ca-based company that is driven by a passion for elevating the science and utility of prenatal testing. the advent of the information age has created a paradigm shift in the fields of computing and informatics. surprisingly, medical diagnostics have been slow to integrate these advances into genetic testing. until natera. from conception to delivery, natera is pioneering next-generation accuracy and reliability in preconception and prenatal genetic testing services, enabling couples to be informed about their pregnancy each step of the way. the company offers a wide range of tests from preimplantation genetic diagnosis (pgd) for ivf to breakthrough advances in the field of non-invasive prenatal testing (nipt). using advances from the human genome project and powered by sophisticated proprietary bioinformatic algorithms, natera’s comprehensive portfolio of tests, proven science, and experienced genetic counseling services deliver the most accurate results in the